Novo Nordisk AS is lowering prices of its top-selling WeGovy weight-loss drug in China, as the Danish drugmaker braces for intense competition from local rivals next year when the patent for its ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Highmark recently shared how it increased generic and biosimilar access to members, focusing on drugs for multiple sclerosis, cancer and autoimmune conditions. The insurer has been working with ...

Cuban said the high fees the FDA charges to approve generic drugs are a major barrier to manufacturing lower-priced generics in the United States, according to the report. Cuban said Cost Plus Drugs, ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. A similar scenario is now ...

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...

Struggling with Java Install Error 1603 on Windows 11? Discover proven, step-by-step fixes to resolve this frustrating issue ...

There's a sweetness at the heart of Alex Woo's "In Your Dreams," but a movie about imagination can't afford to have so little of its own. Twelve-year-old Stevie Ting (voiced by Jolie Hoang-Rappaport) ...

If the most creativity an animated film primarily set in children’s dreams can conjure up is a pizza-themed version of “Don’t Cha” (“Don’t cha wish your pizza was a freak like me?” an animatronic ...

A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...

CEO Narasimhan says no tariff impact on guidance Top-selling heart drug Entresto sees growth stall Older drugs hit by 'generic erosion' in US market Newer drugs help offset some of the slowdown ...

NEW YORK – Novartis is optimistic that revenue from its blockbusters and therapies resulting from new acquisitions, including a recent $12 billion bid for the mRNA therapeutics company Avidity ...